C1QTNF6 and urinary bladder carcinoma: Respective results indicated that, in patients with high C1QTNF6 levels, genes that were enriched in particular networks, including bladder cancer, cytokine-cytokine receptor interaction, ECM receptor interaction, ERBB signaling pathway, and melanoma, varied significantly (Figure 6).